Table 2 Anti-tumor effect of both groups
Total (n = 54) | NRT group (n = 28) | NCRT group (n = 26) | |
|---|---|---|---|
Complete response, n (%) | 6 (11.1%) | 2 (7.1%) | 4 (15.4%) |
Partial response, n (%) | 44 (81.5%) | 23 (82.1%) | 21 (80.8%) |
Stable disease, n (%) | 2 (3.7%) | 2 (7.1%) | 0 (0) |
Progressive disease, n (%) | 2 (3.7%) | 1 (3.6%) | 1 (3.8%) |
Objective response rate | 92.6% | 89.2% | 96.2% |
Median OS, months | 16.0 | 9.0 | 24.0 |
Median PFS, months | 10.0 | 7.0 | 17.0 |